{"protocolSection": {"identificationModule": {"nctId": "NCT02693691", "orgStudyIdInfo": {"id": "SJM-CIP-10105"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "CardioMEMS European Monitoring Study for Heart Failure", "officialTitle": "CardioMEMS European Monitoring Study for Heart Failure", "acronym": "MEMS-HF"}, "statusModule": {"statusVerifiedDate": "2022-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-05"}, "primaryCompletionDateStruct": {"date": "2019-03-31", "type": "ACTUAL"}, "completionDateStruct": {"date": "2020-03-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-02-20", "studyFirstSubmitQcDate": "2016-02-23", "studyFirstPostDateStruct": {"date": "2016-02-29", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-06-19", "resultsFirstSubmitQcDate": "2020-07-31", "resultsFirstPostDateStruct": {"date": "2020-08-14", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-04-01", "lastUpdatePostDateStruct": {"date": "2022-04-05", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to characterize the use of the CardioMEMS\u2122 HF System when used in a real-world setting."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 239, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "CardioMEMS HF System", "type": "EXPERIMENTAL", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.", "interventionNames": ["Device: CardioMEMS HF System"]}], "interventions": [{"type": "DEVICE", "name": "CardioMEMS HF System", "description": "Pulmonary Artery Pressure Monitoring", "armGroupLabels": ["CardioMEMS HF System"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Freedom From Device/System Related Complications", "description": "This primary safety endpoints is freedom from device/system related complications (DSRCs) which is defined as an adverse event that is, or is possibly, related to the device/system (wireless pressure sensor or external electronics) and has at least one of the following characteristics: is treated with invasive means (other than intramuscular medication or right heart cauterization which is used for diagnostic purposes); results in death of the subject; or results in the explant of the device. The pre-specified goal of this endpoint was was to have a freedom from DSRC greater than 0.80 at 12 months post-implant.", "timeFrame": "one year"}, {"measure": "Freedom From Pressure Sensor Failure", "description": "This primary safety endpoints is freedom from pressure sensor failure greater than 0.90 at 12 months post-implant.", "timeFrame": "one year"}, {"measure": "Percent of Successful Pulmonary Artery Pressure Data Transmissions", "description": "Patient data transmission success is defined as the percentage of successful transmissions among attempted transmissions. All subjects who were consented and implanted with a pressure sensor regardless of study completion status are included in this analysis. All attempted data transmissions through the 12-month visit or death or withdrawal are included in the analysis. For each subject, the patient data transmission success rate (% of successful transmission) was calculated as total number of successful transmissions divided by total attempted transmissions within 12 months.", "timeFrame": "one year"}], "secondaryOutcomes": [{"measure": "Heart Failure Hospitalization (HFH) Rate", "description": "Comparison of the annualized heart failure hospitalization (HFH) rate (including recurrent events) at 12 months post-implant with the rate (including recurrent events) 12 months prior to implant.", "timeFrame": "one year"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Indicated to receive a CardioMEMS sensor implant per the CardioMEMS\u2122 HF System User's Manual\n* \u2265 18 years of age\n* Diagnosis of New York Heart Association (NYHA) Class III Heart Failure at the time of sensor implantation\n* Hospitalization for worsening HF, as defined in the protocol, within 12 months prior to the CardioMEMS HF System implant\n* Subjects with reduced Left Ventricular Ejection Fraction (LVEF) must be on stable Guideline Directed Medical Therapy (GDMT) as tolerated\n* Written informed consent obtained from subject\n\nExclusion Criteria:\n\n* Known coagulation disorders or inability to take two types of blood thinning medications for one month after the sensor is implanted\n* Subjects deemed a candidate for transplant, Ventricular Assist Device, or hospice care in the next 12 months or are otherwise not expected to be able to complete the study follow up", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Christiane Angermann, Prof. Dr.", "affiliation": "Deutsches Zentrum f\u00fcr Herzinsuffizienz W\u00fcrzburg", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Michael Boehm, Prof. Dr.", "affiliation": "University Hospital, Saarland", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Klinukum Coburg", "city": "Coburg", "state": "Bavaria", "zip": "96450", "country": "Germany", "geoPoint": {"lat": 50.25937, "lon": 10.96384}}, {"facility": "Universit\u00e4tsklinikum W\u00fcrzburg", "city": "W\u00fcrzburg", "state": "Bavaria", "zip": "97080", "country": "Germany", "geoPoint": {"lat": 49.79391, "lon": 9.95121}}]}, "referencesModule": {"references": [{"pmid": "34738340", "type": "DERIVED", "citation": "Bohm M, Assmus B, Anker SD, Asselbergs FW, Brachmann J, Brett ME, Brugts JJ, Ertl G, Wang A, Hilker L, Koehler F, Rosenkranz S, Leistner DM, Abdin A, Wintrich J, Zhou Q, Adamson PB, Angermann CE. Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring. ESC Heart Fail. 2022 Feb;9(1):155-163. doi: 10.1002/ehf2.13665. Epub 2021 Nov 4."}, {"pmid": "29777373", "type": "DERIVED", "citation": "Angermann CE, Assmus B, Anker SD, Brachmann J, Ertl G, Kohler F, Rosenkranz S, Tschope C, Adamson PB, Bohm M. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF). Clin Res Cardiol. 2018 Nov;107(11):991-1002. doi: 10.1007/s00392-018-1281-8. Epub 2018 May 19."}]}, "ipdSharingStatementModule": {"ipdSharing": "UNDECIDED"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Three of the 239 subjects enrolled withdrew before implantation was attempted. Of the 236 subjects who had an attempted implant, two subjects were not implanted. One subject was not implanted because there was a failure to meet screening criteria and the other subject experienced an AE during the implant procedure and was not implanted.", "recruitmentDetails": "The study enrolled a total of 239 subjects at 31 investigational sites in Germany, The Netherlands, and Ireland. The first subject was enrolled on 13 May 2016 and the last subject was enrolled on 29 March 2018. The last 12-month follow-up was completed on 19 March 2019. Data was collected until the database closure date, 28 June 2019.", "groups": [{"id": "FG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring"}], "periods": [{"title": "Primary Endpoint Analysis (First 12M)", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "234"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "184"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "50"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "30"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "12"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "7"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}, {"title": "Extended Follow-Up (Until Last pt 12M)", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "184"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "160"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "24"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "12"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "11"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "68.1", "spread": "10.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "53"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "186"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Germany", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "216"}]}]}, {"title": "Netherlands", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "19"}]}]}, {"title": "Ireland", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "4"}]}]}]}, {"title": "BMI", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "28.8", "spread": "5.3"}]}]}]}, {"title": "Ejection Fraction", "description": "Ejection fraction (EF) is a measurement of the percentage of blood leaving the heart each time it contracts. Heart failure patients with an EF \\<40% are considered to have reduced ejection fraction (HFrEF) where as patients with an EF \\>=40% are considered to have preserved ejection fraction (HFpEF).", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "HFrEF (EF < 40%)", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "168"}]}]}, {"title": "HFpEF (EF \u2265 40%)", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "68"}]}]}, {"title": "Unknown", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}]}]}]}, {"title": "HF Etiology", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Ischemic Cardiomyopathy", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "128"}]}]}, {"title": "Non-Ischemic Cardiomyopathy", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "87"}]}]}, {"title": "Unknown", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "239"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "24"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Freedom From Device/System Related Complications", "description": "This primary safety endpoints is freedom from device/system related complications (DSRCs) which is defined as an adverse event that is, or is possibly, related to the device/system (wireless pressure sensor or external electronics) and has at least one of the following characteristics: is treated with invasive means (other than intramuscular medication or right heart cauterization which is used for diagnostic purposes); results in death of the subject; or results in the explant of the device. The pre-specified goal of this endpoint was was to have a freedom from DSRC greater than 0.80 at 12 months post-implant.", "populationDescription": "Safety population", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of patients", "timeFrame": "one year", "groups": [{"id": "OG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "239"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "98.3", "lowerLimit": "95.8", "upperLimit": "100"}]}]}]}, {"type": "PRIMARY", "title": "Freedom From Pressure Sensor Failure", "description": "This primary safety endpoints is freedom from pressure sensor failure greater than 0.90 at 12 months post-implant.", "populationDescription": "Safety population", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of patients", "timeFrame": "one year", "groups": [{"id": "OG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "239"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "99.6", "lowerLimit": "97.6", "upperLimit": "100"}]}]}]}, {"type": "PRIMARY", "title": "Percent of Successful Pulmonary Artery Pressure Data Transmissions", "description": "Patient data transmission success is defined as the percentage of successful transmissions among attempted transmissions. All subjects who were consented and implanted with a pressure sensor regardless of study completion status are included in this analysis. All attempted data transmissions through the 12-month visit or death or withdrawal are included in the analysis. For each subject, the patient data transmission success rate (% of successful transmission) was calculated as total number of successful transmissions divided by total attempted transmissions within 12 months.", "populationDescription": "All subjects who were consented and implanted with a pressure sensor regardless of study completion status were included in the analysis.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of successful transmissions", "timeFrame": "one year", "groups": [{"id": "OG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "234"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "91.7", "spread": "13.0"}]}]}]}, {"type": "SECONDARY", "title": "Heart Failure Hospitalization (HFH) Rate", "description": "Comparison of the annualized heart failure hospitalization (HFH) rate (including recurrent events) at 12 months post-implant with the rate (including recurrent events) 12 months prior to implant.", "populationDescription": "All subjects who were consented and implanted with a pressure sensor regardless of study completion status were included in the analysis.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Hazard Ratio", "timeFrame": "one year", "groups": [{"id": "OG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "234"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.38", "lowerLimit": "0.31", "upperLimit": "0.48"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "AEs were collected starting from enrollment and until the last patient completed 12 months follow-up.", "description": "Non-serious Adverse Events were not collected as part of the protocol.", "eventGroups": [{"id": "EG000", "title": "CardioMEMS HF System", "description": "Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.\n\nCardioMEMS HF System: Pulmonary Artery Pressure Monitoring", "deathsNumAffected": 42, "deathsNumAtRisk": 234, "seriousNumAffected": 184, "seriousNumAtRisk": 239, "otherNumAffected": 0, "otherNumAtRisk": 0}], "seriousEvents": [{"term": "Blood and lymphatic system disorders", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 6, "numAtRisk": 239}]}, {"term": "Abnormal heart rate or rhythm", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 61, "numAffected": 43, "numAtRisk": 239}]}, {"term": "Decompensated HF", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 190, "numAffected": 103, "numAtRisk": 239}]}, {"term": "Other cardiac disorders", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 85, "numAffected": 57, "numAtRisk": 239}]}, {"term": "Endocrine disorders", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 9, "numAtRisk": 239}]}, {"term": "Gastrointestinal disorders", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 24, "numAffected": 21, "numAtRisk": 239}]}, {"term": "General disorders", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 49, "numAffected": 38, "numAtRisk": 239}]}, {"term": "Hepatobiliary disorders", "organSystem": "Hepatobiliary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 239}]}, {"term": "Immune system disorders", "organSystem": "Immune system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 239}]}, {"term": "Infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 72, "numAffected": 51, "numAtRisk": 239}]}, {"term": "Other infections and infestations", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 239}]}, {"term": "Injury, poisoning, and procedural complications", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 22, "numAffected": 19, "numAtRisk": 239}]}, {"term": "Investigations", "organSystem": "Investigations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 239}]}, {"term": "Metabolism and nutrition disorders", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 239}]}, {"term": "Neoplasms benign, malignant and unspecified (including cysts and polyps)", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 239}]}, {"term": "Nervous system disorders", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 239}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 43, "numAffected": 34, "numAtRisk": 239}]}, {"term": "Other renal and urinary disorders", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 239}]}, {"term": "Reproductive system and breast disorders", "organSystem": "Reproductive system and breast disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 239}]}, {"term": "Respiratory, thoracic and mediastinal disorders", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 11, "numAtRisk": 239}]}, {"term": "Skin and subcutaneous tissue disorders", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 239}]}, {"term": "Surgical and medical procedures", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 239}]}, {"term": "Vascular disorders", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 17, "numAtRisk": 239}]}, {"term": "Musculoskeletal and connective tissue disorders", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 9, "numAtRisk": 239}]}, {"term": "Eye disorders", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 239}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Marie-Elena Brett", "organization": "Abbott", "email": "marieelena.brett@abbott.com", "phone": "7815283613"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP_ICF", "hasProtocol": true, "hasSap": true, "hasIcf": true, "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form", "date": "2017-09-19", "uploadDate": "2020-07-21T17:02", "filename": "Prot_SAP_ICF_000.pdf", "size": 1151477}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}